文献速递消化道出血

低剂量阿司匹林使用者下消化道出血风险研究

The risk of lower gastrointestinal bleeding in low-dose aspirin users.
PubMed 文献 · Aliment Pharmacol Ther · 2017-04-27

该研究基于台湾全民健康保险研究数据库百万人随机抽样,纳入低剂量阿司匹林(每日75-325毫克)使用者及按年龄、性别、入组时间1:5匹配的对照。共纳入53 805例阿司匹林使用者和269 025例对照,阿司匹林组1年内下消化道出血发生率高于对照组(0.20% vs 0.06%,P<.0001)。低剂量阿司匹林、NSAIDs、类固醇、SSRIs、PPIs和H2RAs为下消化道出血的独立危险因素。

要点

  • 低剂量阿司匹林使用者1年内下消化道出血发生率为0.20%,高于对照组的0.06%(P<.0001)。
  • 阿司匹林与下消化道出血相关(HR 2.75,95%CI 2.06-3.65)。
  • NSAIDs、类固醇、SSRIs、PPIs和H2RAs亦与下消化道出血显著相关。

核心结论

  • 在全国性队列中,低剂量阿司匹林使用者的下消化道出血风险高于非使用者。
  • 低剂量阿司匹林、NSAIDs、类固醇、SSRIs、PPIs和H2RAs是下消化道出血的独立危险因素。

研究设计与样本

  • 采用Cox比例风险回归模型评估下消化道出血的预测因素,并对年龄、性别、合并症及合并用药进行调整。
  • 共纳入53 805例阿司匹林使用者和269 025例对照。

主要发现

  • 阿司匹林组1年内下消化道出血发生率高于对照组(0.20% vs 0.06%,P<.0001)。
  • 阿司匹林与下消化道出血显著相关(HR 2.75,95%CI 2.06-3.65)。
  • NSAIDs与下消化道出血显著相关(HR 8.61,95%CI 3.28-22.58)。
  • 类固醇与下消化道出血显著相关(HR 10.50,95%CI 1.98-55.57)。
  • SSRIs与下消化道出血显著相关(HR 11.71,95%CI 1.40-97.94);PPIs(HR 8.47,95%CI 2.26-31.71)和H2RAs(HR 10.83,95%CI 2.98-39.33)亦与下消化道出血显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aspirin increases the risk of gastrointestinal bleeding. AIM: To investigate the risk of lower gastrointestinal bleeding (LGIB) in aspirin users. METHODS: Low-dose (75-325 mg daily) aspirin users and controls matched by age, gender and enrollment time in a 1:5 ratio were selected from 1 million randomly sampled subjects in the National Health Insurance Research Database of Taiwan. Cox proportional hazard regression models were developed to evaluate the predictors of LGIB with adjustments for age, gender, comorbidities including coronary artery disease, ischaemic stroke, diabetes, hypertension, chronic kidney disease, liver cirrhosis, chronic obstructive pulmonary disease, dyslipidemia, uncomplicated peptic ulcer disease, history of peptic ulcer bleeding, and concomitant use of clopidogrel, ticlopidine, warfarin, nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase-2 inhibitors, steroids, proton pump inhibitors (PPIs), histamine-2 receptor antagonists (H2RAs), nitrates, alendronate, selective serotonin reuptake inhibitors (SSRIs) and calcium channel blockers. RESULTS: A total of 53 805 aspirin users and 269 025 controls were included. Aspirin group had a higher incidence of LGIB within 1 year than control group (0.20% vs 0.06%, P<.0001). Aspirin (hazard ratio [HR]: 2.75, 95% confidence interval [CI]: 2.06-3.65), NSAIDs (HR: 8.61, 95% CI: 3.28-22.58), steroids (HR: 10.50, 95% CI: 1.98-55.57), SSRIs (HR: 11.71, 95% CI: 1.40-97.94), PPIs (HR: 8.47, 95% CI: 2.26-31.71), and H2RAs (HR: 10.83, 95% CI: 2.98-39.33) were significantly associated with LGIB. CONCLUSIONS: The risk of LGIB was higher in low-dose aspirin users than in aspirin nonusers in this nationwide cohort. Low-dose aspirin, NSAIDs, steroids, SSRIs, PPIs and H2RAs were independent risk factors for LGIB.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Chen WC, Lin KH, Huang YT, et al. The risk of lower gastrointestinal bleeding in low-dose aspirin users. Aliment Pharmacol Ther. 2017. PMID: 28449186. doi:10.1111/apt.14079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。